Randomized phase II trial of DCF-R vs CF-R in unresectable and recurrent esophageal cancer - Randomized phase II trialof DCF-R vs CF-R

Gunma University Hospital Integrative center of general surgery0 个研究点目标入组 52 人开始时间: 2015年7月28日最近更新: 2023年10月17日

试验速览

暂无简介。

•1)The patients with a history of severe drug hypersensitivity. 2)Pregnant women or women that might be pregnant. Men who wish to partner pregnancy. 3)patients with active infection (fever over 38 degree). 4)cases of serious complications (interstitial pneumonia or pulmonary fibrosis, kidney failure, liver failure, poor control of diabetes, control such as failure of the high blood pressure). 5)significant ECG abnormalities are observed cases or heart disease (heart failure to be a clinical problem, myocardial infarction, patients with angina pectoris). 6)the active gastrointestinal tract ulcers or patients with bleeding. 7)patients with sensory neuropathy. 8)Serious cases of diarrhea. 9)patients with ascites and pleural effusion requiring drainage by continuous drainage detention. 10)patients with brain metastases or case to suspect brain metastases from clinical symptoms 11)patient with cancer of less than five years disease-free period (healing skin basal cell cancer and cervical cancer or endoscopic mucosal resection by healing, it has been confirmed, esophageal cancer, colon pM cases of cancer I and registration available). 12)patients undergoing continuous systemic administration of steroids. cases 13)attending physician is considered unsuitable for participation in the study. 14)Docetaxel, case is the administration contraindication of CDDP, 5-FU.

发起方

Gunma University Hospital Integrative center of general surgery